Article
January 26, 2017
The NINDS award provides longer-term support and increased flexibility to pursue innovative, high-risk research on neurological diseases.
Multiple Sclerosis
Akassoglou Lab
Article
October 12, 2016
Katerina Akassoglou is calling for a fundamental change in the way scientists approach neurological disorders. Her research on the brain’s vascular and immune systems has led to new insights about multiple sclerosis and other conditions.
Multiple Sclerosis
Akassoglou Lab
Article
September 7, 2016
The NINDS award provides longer-term support and increased flexibility to pursue innovative, high-risk research on neurological diseases.
Neurological Disease
Akassoglou Lab
Article
October 9, 2015
A new study from the Gladstone Institutes shows that a single drop of blood in the brain is sufficient to activate an autoimmune response akin to multiple sclerosis (MS).
Akassoglou Lab
Multiple Sclerosis
Article
September 10, 2015
Victoria Rafalski, a postdoctoral scholar in the Akassoglou lab, encourages young scientists to pursue a career that aligns with their personal values.
Akassoglou Lab
Article
January 29, 2015
Katerina Akassoglou is working to identify a biomarker that could track the progression of multiple sclerosis using blood tests
Akassoglou Lab
Multiple Sclerosis
December 4, 2013
SAN FRANCISCO, CA—For some, the disease multiple sclerosis (MS) attacks its victims slowly and progressively over a period of many years. For others, it strikes without warning in fits and starts.
Akassoglou Lab
Neurological Disease
Multiple Sclerosis
June 17, 2013
SAN FRANCISCO, CA—Inside each of us is our own internal timing device. It drives everything from sleep cycles to metabolism, but the inner-workings of this so-called “circadian clock” are complex, and the molecular processes behind it have long eluded scientists.
Akassoglou Lab
Metabolism
November 26, 2012
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis (MS)—a disease that causes progressive and irreversible damage to nerve cells in the brain and spinal cord.
Akassoglou Lab
Multiple Sclerosis
March 27, 2012
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have discovered a key protein that regulates insulin resistance—the diminished ability of cells to respond to the action of insulin and which sets the stage for the development of the most common form of diabetes.
Akassoglou Lab
Diabetes
Metabolism
July 20, 2010
SAN FRANCISCO, CA—The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases.
Akassoglou Lab
Multiple Sclerosis
